Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11  •  04:00PM ET
29.66
Dollar change
+0.86
Percentage change
3.00
%
IndexRUT P/E- EPS (ttm)-17.02 Insider Own1.02% Shs Outstand67.90M Perf Week6.61%
Market Cap2.01B Forward P/E11.92 EPS next Y2.49 Insider Trans3.96% Shs Float67.24M Perf Month35.50%
Enterprise Value4.76B PEG0.58 EPS next Q0.42 Inst Own121.62% Short Float17.07% Perf Quarter3.82%
Income-1.15B P/S0.74 EPS this Y12.50% Inst Trans3.63% Short Ratio8.13 Perf Half Y-0.74%
Sales2.72B P/B0.99 EPS next Y19.53% ROA-18.51% Short Interest11.48M Perf YTD-33.42%
Book/sh29.99 P/C20.54 EPS next 5Y20.40% ROE-44.21% 52W High49.45 -40.02% Perf Year-26.82%
Cash/sh1.44 P/FCF- EPS past 3/5Y- - ROIC-24.62% 52W Low19.50 52.10% Perf 3Y-67.83%
Dividend Est.- EV/EBITDA8.65 Sales past 3/5Y17.92% 39.10% Gross Margin40.21% Volatility4.44% 5.16% Perf 5Y-84.68%
Dividend TTM- EV/Sales1.75 EPS Y/Y TTM38.98% Oper. Margin4.11% ATR (14)1.39 Perf 10Y35.87%
Dividend Ex-Date- Quick Ratio0.98 Sales Y/Y TTM-3.43% Profit Margin-42.48% RSI (14)65.12 Recom2.62
Dividend Gr. 3/5Y- - Current Ratio1.78 EPS Q/Q-3545.38% SMA2016.02% Beta0.60 Target Price36.29
Payout- Debt/Eq1.40 Sales Q/Q-3.66% SMA5011.88% Rel Volume0.95 Prev Close28.80
Employees6600 LT Debt/Eq1.30 EarningsNov 05 AMC SMA2002.42% Avg Volume1.41M Price29.66
IPOFeb 01, 1991 Option/ShortYes / Yes EPS/Sales Surpr.55.37% 4.57% Trades Volume1,343,682 Change3.00%
Date Action Analyst Rating Change Price Target Change
Oct-07-25Downgrade Citigroup Buy → Neutral $33
May-08-25Upgrade Jefferies Hold → Buy $44
Dec-11-24Upgrade Citigroup Neutral → Buy $44 → $50
Dec-10-24Initiated Jefferies Hold $43
Sep-19-24Resumed UBS Neutral $42 → $50
Sep-05-24Upgrade Craig Hallum Hold → Buy $40 → $57
Mar-04-24Downgrade UBS Neutral → Sell $70 → $42
Feb-14-24Downgrade JP Morgan Neutral → Underweight $66 → $37
Dec-11-23Downgrade Citigroup Buy → Neutral $95 → $72
Dec-12-22Upgrade Citigroup Neutral → Buy $90 → $125
Dec-03-25 11:45AM
Nov-25-25 01:00PM
Nov-24-25 07:00AM
Nov-21-25 05:15PM
Nov-20-25 09:00AM
12:35AM Loading…
Nov-12-25 12:35AM
Nov-06-25 01:25PM
11:37AM
09:16AM
12:12AM
Nov-05-25 04:54PM
04:52PM
04:05PM
Nov-03-25 10:04PM
07:00AM
08:25AM Loading…
Oct-30-25 08:25AM
Oct-29-25 07:30AM
Oct-23-25 06:45PM
12:44AM
Oct-22-25 07:00AM
Oct-20-25 01:36PM
Oct-16-25 08:30PM
Oct-07-25 11:30AM
Sep-30-25 09:30AM
Sep-26-25 09:53AM
Sep-25-25 09:00AM
Sep-23-25 11:31PM
Sep-22-25 07:00AM
Sep-18-25 11:30AM
Sep-10-25 12:20AM
07:30AM Loading…
Aug-28-25 07:30AM
Aug-21-25 04:30PM
09:00AM
Aug-19-25 04:05PM
Aug-18-25 12:02AM
Aug-14-25 11:13AM
Aug-13-25 03:00PM
12:10AM
Aug-12-25 11:59PM
Aug-08-25 09:45AM
Aug-07-25 09:40AM
Aug-06-25 01:02PM
03:36AM
Aug-05-25 05:57PM
05:14PM
04:10PM
Aug-04-25 01:32PM
Aug-03-25 11:12PM
Jul-29-25 05:00PM
Jul-28-25 12:01PM
Jul-24-25 09:00AM
Jul-22-25 04:30PM
Jul-18-25 03:10PM
Jul-17-25 07:00AM
Jul-16-25 09:39AM
Jul-14-25 07:00AM
07:00AM
Jul-09-25 11:38PM
Jul-08-25 07:42AM
Jul-07-25 10:21AM
07:00AM
Jul-04-25 09:45AM
09:40AM
Jun-24-25 10:43AM
Jun-18-25 12:00PM
09:45AM
09:40AM
Jun-16-25 12:01AM
Jun-11-25 06:56AM
12:32AM
Jun-06-25 11:31AM
Jun-03-25 04:10PM
09:50AM
Jun-02-25 09:45AM
May-22-25 04:30PM
May-21-25 09:44AM
May-16-25 09:50AM
May-15-25 09:45AM
May-09-25 12:01PM
12:41AM
May-08-25 12:10PM
03:38AM
May-07-25 07:56PM
07:56PM
06:10PM
04:05PM
May-06-25 10:13AM
May-01-25 07:27AM
Apr-30-25 07:56PM
10:01AM
Apr-28-25 09:06AM
Apr-25-25 09:15AM
Apr-24-25 12:10PM
Apr-23-25 04:30PM
Apr-10-25 11:34AM
Apr-09-25 01:35PM
Apr-04-25 05:04AM
Mar-10-25 09:00AM
Mar-06-25 04:02AM
Mar-04-25 11:49PM
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RHOADS ANN DDirectorDec 10 '25Buy28.2775021,20615,021Dec 10 06:37 PM
Wilkins Joseph D Jr.DirectorNov 26 '25Buy27.9537010,34311,876Dec 01 04:33 PM
WIDDER KENNETH JDirectorNov 25 '25Option Exercise15.747,021110,51141,087Nov 25 04:16 PM
WIDDER KENNETH JDirectorNov 25 '25Sale27.814,026111,96537,061Nov 25 04:16 PM
KENNETH WIDDERDirectorNov 25 '25Proposed Sale27.814,026111,965Nov 25 04:11 PM
Busky Joseph M.Chief Financial OfficerNov 24 '25Buy26.064,770124,3056,920Nov 25 01:21 PM
POLAN MARY LAKE PH DDirectorNov 21 '25Buy22.431,00022,43012,640Nov 24 04:09 PM
Blaser Brian J.President and CEONov 19 '25Buy21.3423,500501,57729,533Nov 20 04:16 PM
BUECHLER KENNETH FDirectorJul 15 '25Option Exercise15.749,215145,044101,921Jul 17 04:09 PM
The Bujarski 2007 Trust U/A DtFormer COOJan 06 '25Proposed Sale47.50100,2004,759,500Jan 06 12:58 PM
Last Close
Dec 11  •  04:00PM ET
88.88
Dollar change
+1.06
Percentage change
1.21
%
GMED Globus Medical Inc daily Stock Chart
Index- P/E28.72 EPS (ttm)3.09 Insider Own17.25% Shs Outstand112.18M Perf Week0.16%
Market Cap11.96B Forward P/E22.06 EPS next Y4.03 Insider Trans-0.41% Shs Float111.38M Perf Month4.64%
Enterprise Value11.69B PEG1.83 EPS next Q1.07 Inst Own88.31% Short Float3.95% Perf Quarter51.31%
Income423.78M P/S4.32 EPS this Y20.78% Inst Trans3.48% Short Ratio2.55 Perf Half Y47.64%
Sales2.77B P/B2.72 EPS next Y6.24% ROA8.32% Short Interest4.40M Perf YTD7.46%
Book/sh32.68 P/C30.64 EPS next 5Y12.04% ROE10.01% 52W High94.93 -6.37% Perf Year7.19%
Cash/sh2.90 P/FCF20.64 EPS past 3/5Y-19.65% -13.26% ROIC9.41% 52W Low51.79 71.62% Perf 3Y28.91%
Dividend Est.- EV/EBITDA16.13 Sales past 3/5Y38.03% 26.25% Gross Margin61.05% Volatility2.22% 2.63% Perf 5Y46.30%
Dividend TTM- EV/Sales4.22 EPS Y/Y TTM364.73% Oper. Margin16.20% ATR (14)2.40 Perf 10Y239.50%
Dividend Ex-Date- Quick Ratio2.47 Sales Y/Y TTM11.75% Profit Margin15.30% RSI (14)65.13 Recom1.93
Dividend Gr. 3/5Y- - Current Ratio4.13 EPS Q/Q134.07% SMA201.61% Beta1.07 Target Price95.70
Payout0.00% Debt/Eq0.03 Sales Q/Q22.91% SMA5021.34% Rel Volume0.67 Prev Close87.82
Employees5300 LT Debt/Eq0.02 EarningsNov 06 AMC SMA20035.35% Avg Volume1.72M Price88.88
IPOAug 03, 2012 Option/ShortYes / Yes EPS/Sales Surpr.51.13% 4.68% Trades Volume1,157,004 Change1.21%
Date Action Analyst Rating Change Price Target Change
Nov-07-25Upgrade Truist Hold → Buy $93
Nov-07-25Upgrade BofA Securities Neutral → Buy $91
Oct-28-25Resumed Stifel Hold $64
May-27-25Downgrade BTIG Research Buy → Neutral
Jan-10-25Upgrade BofA Securities Underperform → Neutral $97
Dec-02-24Upgrade Morgan Stanley Equal-Weight → Overweight $83 → $100
Aug-07-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $78
May-20-24Upgrade Piper Sandler Neutral → Overweight $60 → $80
Mar-18-24Upgrade BTIG Research Neutral → Buy $60
Oct-20-23Initiated ROTH MKM Buy $75
Dec-10-25 01:35PM
Dec-08-25 10:33PM
Dec-04-25 11:43AM
09:45AM
08:27AM
12:45PM Loading…
Dec-03-25 12:45PM
12:43PM
11:40AM
09:40AM
08:14AM
08:08AM
Dec-02-25 09:50AM
08:25AM
07:53AM
Dec-01-25 05:12PM
09:04AM Loading…
09:04AM
07:52AM
Nov-26-25 03:27AM
Nov-25-25 02:42PM
08:24AM
07:03AM
Nov-24-25 05:15PM
01:47PM
11:35AM
09:55AM
Nov-20-25 05:46PM
09:16AM
Nov-19-25 01:45PM
Nov-18-25 01:56PM
Nov-17-25 09:33AM
12:45PM Loading…
Nov-14-25 12:45PM
10:19AM
09:50AM
08:21AM
Nov-13-25 08:52AM
12:35AM
Nov-11-25 09:45AM
Nov-10-25 11:41PM
Nov-09-25 12:40PM
Nov-07-25 04:21PM
04:14PM
02:17PM
01:11PM
11:08AM
11:04AM
09:26AM
06:36AM
Nov-06-25 07:30PM
06:55PM
05:55PM
05:08PM
04:15PM
Nov-05-25 07:10PM
11:54AM
09:15AM
Nov-04-25 10:12PM
06:20PM
08:39AM
08:39AM
08:38AM
Oct-31-25 10:15AM
Oct-30-25 10:00AM
Oct-29-25 09:40AM
Oct-28-25 05:15PM
09:16AM
Oct-24-25 09:00AM
Oct-23-25 07:53AM
Oct-17-25 09:08AM
Oct-16-25 04:30PM
Oct-14-25 04:40PM
11:40AM
08:34AM
Oct-06-25 11:33PM
Oct-02-25 10:13AM
Oct-01-25 12:01AM
Sep-29-25 09:40AM
Sep-12-25 09:40AM
Sep-04-25 12:14PM
Sep-02-25 01:05AM
Aug-28-25 04:30PM
Aug-27-25 09:40AM
08:29AM
Aug-19-25 07:55AM
Aug-14-25 01:33AM
Aug-13-25 08:51AM
08:22AM
Aug-11-25 09:41AM
09:40AM
Aug-08-25 12:21PM
05:16AM
Aug-07-25 07:00PM
06:05PM
05:08PM
04:15PM
Aug-06-25 09:15AM
07:10AM
Aug-05-25 11:11PM
Jul-31-25 10:00AM
Jul-28-25 11:11AM
Jul-25-25 08:40AM
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Paul David CExecutive ChairmanDec 08 '25Option Exercise25.5234,375877,25060,417Dec 10 04:37 PM
Kline KyleSenior Vice President, CFODec 01 '25Option Exercise59.8618,5421,109,87618,542Dec 03 08:23 PM
Kline KyleSenior Vice President, CFODec 01 '25Sale90.0018,5421,668,7800Dec 03 08:23 PM
Kline KyleOfficerDec 01 '25Proposed Sale89.9518,5421,667,847Dec 01 03:59 PM
Huller KellySVP, GC, Corporate SecretaryNov 25 '25Option Exercise25.967,500194,7007,500Nov 28 05:31 PM
Huller KellySVP, GC, Corporate SecretaryNov 25 '25Sale90.007,500675,0000Nov 28 05:31 PM
Huller KellyOfficerNov 25 '25Proposed Sale90.007,500675,000Nov 25 11:07 AM
Davidar David DDirectorNov 12 '25Option Exercise25.5225,000638,000541,275Nov 13 05:12 PM
Davidar David DDirectorNov 12 '25Sale86.0025,0002,150,005516,275Nov 13 05:12 PM
ZARRILLI STEPHEN TDirectorNov 11 '25Option Exercise44.1425,0001,103,50025,000Nov 13 05:06 PM
ZARRILLI STEPHEN TDirectorNov 11 '25Sale84.2925,0002,107,2580Nov 13 05:06 PM
Davidar David DDirectorNov 12 '25Proposed Sale85.9525,0002,148,750Nov 12 12:35 PM
ZARRILLI STEPHEN TDirectorNov 11 '25Proposed Sale84.2425,0002,106,000Nov 12 08:45 AM
RHOADS ANN DDirectorNov 10 '25Proposed Sale85.002,000170,000Nov 10 04:55 PM
RHOADS ANN DDirectorNov 07 '25Sale81.008,000648,00017,384Nov 10 04:15 PM
RHOADS ANN DDirectorNov 10 '25Sale85.002,000170,00015,384Nov 10 04:15 PM
RHOADS ANN DDirectorNov 07 '25Proposed Sale80.968,000647,681Nov 07 12:17 PM
RHOADS ANN DDirectorSep 15 '25Sale58.4610,000584,60025,384Sep 16 05:16 PM
RHOADS ANN DDirectorSep 15 '25Proposed Sale58.4010,000584,000Sep 15 03:51 PM
RHOADS ANN DDirectorFeb 28 '25Sale78.687,500590,10035,384Mar 04 04:38 PM
RHOADS ANN DDirectorFeb 28 '25Proposed Sale78.677,500590,000Feb 28 11:05 AM
Pfeil Keith WCOO, CFOJan 10 '25Option Exercise51.7814,167733,56114,167Jan 14 04:12 PM
Pfeil Keith WCOO, CFOJan 10 '25Sale88.2914,1671,250,7700Jan 14 04:12 PM
Pfeil Keith WOfficerJan 10 '25Proposed Sale88.2914,1671,250,772Jan 10 11:20 AM